FLAG vs FLAG-IDA: outcomes in relapsed/refractory acute leukemias
Sign Up to like & getrecommendations! Published in 2019 at "Cancer Chemotherapy and Pharmacology"
DOI: 10.1007/s00280-019-03792-8
Abstract: BackgroundFLAG (fludarabine, cytarabine, granulocyte colony—stimulating factor) and FLAG-IDA (idarubicin added to standard FLAG) are salvage chemotherapy regimens used for relapsed and refractory acute leukemias. The toxicity of the FLAG-IDA courses is generally more severe than… read more here.
Keywords: relapsed refractory; flag ida; refractory acute; remission ... See more keywords
Clinical outcome of FLAG-IDA chemotherapy sequential with Flu–Bu3 conditioning regimen in patients with refractory AML: a parallel study from Shanghai Institute of Hematology and Institut Paoli-Calmettes
Sign Up to like & getrecommendations! Published in 2018 at "Bone Marrow Transplantation"
DOI: 10.1038/s41409-018-0283-5
Abstract: The purpose of the study was to evaluate the feasibility of conditioning regimen with sequential chemotherapy (FLAG-IDA), followed by Fludarabine (5 days) + Busulfan (3 days) by parallel analysis of patients with refractory acute myeloid leukemia (AML)… read more here.
Keywords: refractory aml; hematology; flag ida; study ... See more keywords
A Multicenter Nonrandom Clinical Study of Induction Regimen of FLAG-ID and Dae in the Treatment of Childhood De Novo Acute Myeloid Leukemia in South of China:the Early Report of Efficacy and Safety
Sign Up to like & getrecommendations! Published in 2017 at "Blood"
DOI: 10.1182/blood.v130.suppl_1.3873.3873
Abstract: Objective: Complete remission (CR) after induction chemotherapy was one of the important prognostic factors in the treatment of acute myeloid leukemia(AML). Intensive induction regimen have potential of increasing the CR rate, but also followed high… read more here.
Keywords: flag ida; induction; treatment; group ... See more keywords